Digital Health Startups

Predictive Healthcare builds an AI-based postoperative monitoring platform that analyzes wound images, patient-reported inputs, and vital signs to flag patients at elevated risk of surgical site infections and other complications, supporting earlier clinical review. It serves clinicians and their postoperative patients, with the product available in the US.

1 investor

Predilife offers digital preventive health checkups that combine traditional health assessments with predictive medicine and AI to estimate individuals' risk of serious diseases such as breast, prostate, lung and colorectal cancers, melanoma, and cardiovascular disease. It serves companies, brokers and mutual insurers, and healthcare professionals in France, providing risk-based follow-up and personalized recommendations via teleconsultation.

1 investor

PrediSurge develops AI-powered digital twin technology that converts CT scans into patient-specific models to help clinicians plan and execute cardiovascular interventions, particularly aortic endovascular repairs. The company serves vascular surgeons and medical device manufacturers seeking to enhance surgical precision and patient outcomes through predictive, simulation-based decision support.

1 investor

Preface Health provides a patient follow-up and engagement platform that helps healthcare organizations guide patients through care journeys, from post-visit follow-up to appointment scheduling and care coordination. The platform serves primary care, urgent care, specialty care, and health systems to improve patient retention and care continuity.

1 investor

PreGen applies artificial intelligence to gene expression data to develop clinically validated prognostic and predictive molecular tests for cancer patients, starting with prostate cancer. Its tests run on standard PCR equipment with results delivered via a web platform, designed for decentralized deployment in emerging countries, with a focus on Latin America.

1 investor

Smart Human Dynamics develops Pregnancy Coach, a digital health platform that monitors physiological metrics and recommends behaviors to reduce pregnancy complications for expectant mothers. The company focuses on preventing preeclampsia, stillbirth, preterm birth, and other obstetric risks.

1 investor

Pregnolia has developed a medical device that measures cervical stiffness to help health care providers assess cervical status in pregnancy care. The technology originated from research at ETH Zürich and University Hospital Zürich and is being studied as a potential biomarker for preterm birth.

1 investor

Pregnostica develops technology and medical devices that detect pregnancy- and childbirth-related pathologies during the first trimester, using patented biomarkers and algorithms to enable early treatment. Its research targets conditions such as gestational diabetes.

1 investor

Prelude Fertility operates a network of partnerships connecting aspiring parents with fertility treatment providers, including donor egg banks, financial bundling services, virtual pharmacy services, and reproductive health supplements.

1 investor

Premark Pharma develops therapeutic candidates for ophthalmologic conditions including blepharitis and dry eye disease. The company is advancing clinical-stage programs through Phase 3 development.

1 investor

Premier is a clinical laboratory in the Scott/Lafayette area of Louisiana offering blood testing, comprehensive urine drug testing (including designer synthetics), and next-day PCR testing for respiratory illnesses, STDs, UTIs, wound, and women's health. It serves clinics, providers, and their patients with customized lab services.

1 investor

Prena is developing a non-invasive photobiomodulation device — a sleep mask that emits low-intensity cerulean light through the eyelids to down-regulate melatonin and stop or prevent preterm uterine contractions. The product targets expectant mothers at risk of preterm labor within perinatal care and obstetrics/gynecology.

1 investor

Prepared provides a competency-based assessment system for medical and professional trainees to develop workplace-relevant skills. The platform serves medical education institutions and training programs adopting competency-based education models.

1 investor

Presage Technologies offers SmartSpectra, a contactless health-sensing SDK that turns any smartphone camera or webcam into a real-time biometric sensor, extracting vital signs such as heart rate, breathing rate, HRV, and facial expressions without wearables or contact sensors. It targets developers, hospitals, clinics, and health organizations, with FDA 510(k) clearance for heart rate and breathing rate on iOS and Android.

1 investor

Presaj develops a cloud-based clinical decision-support platform that uses AI and engineering techniques to forecast patient-specific risks across procedural, clinical, and social factors for healthcare providers. The platform identifies avoidable adverse events prospectively and delivers actionable insights to prevent complications in community hospitals.

1 investor

PrescriberPoint operates an AI-enabled medication access platform that helps clinicians get patients onto prescribed therapies by providing prescribing support, coverage and cost-savings lookups in one place. It serves healthcare providers in the medication access and prescribing space.

1 investor

Kiri is a pediatric health app that helps parents track and understand their child's patterns around sleep, feeding, symptoms, and development. The app combines daily health observations with clinical guidance to support parental decision-making between home care and medical visits.

1 investor

Press offers health and wellness resources, including a Health Quotient (HQ) assessment that evaluates physical, mental, relational, and baseline health across 28 characteristics. The company connects users with mentors such as professional athletes, special forces members, first responders, and coaches to support physical, mental, and relational improvement.

1 investor

Esopredict is a methylation-based risk-stratification test that quantifies DNA methylation of four genes (p16, RUNX3, HPP1, FBN1) combined with patient age to predict a patient's 5-year risk of progressing from Barrett's esophagus to high-grade dysplasia or esophageal adenocarcinoma. Offered by Castle as a companion to its TissueCypher test, it produces a risk score and risk level to help clinicians manage patients with non-dysplastic, indefinite, or low-grade Barrett's esophagus.

1 investor

Pria offers a HIPAA-compliant technology platform that integrates health-at-home solutions for chronic care management, helping healthcare organizations deliver remote care at scale to patients and members. It focuses on the Medicare population, supporting aging in place and improving adherence to remote care management.

1 investor

Prime Providers offers in-home care, respite, and supportive services for individuals with intellectual and developmental disabilities (I/DD), including personal care, companionship, skill-building, and community integration. It serves individuals and families across California and Oregon using a person-centered approach with trained caregivers.

1 investor

PrimeTime develops mobile entertainment and wellbeing experiences for people aged 60 and older, combining games with cognitive stimulation, training, and social engagement. Its PrimeTime+ subscription offers brain games and puzzles, perks and discounts, curated travel and social experiences, and hobby and learning content.

1 investor

Prism TPO provides a drug pricing transparency platform for independent oncology practices, integrating distributor pricing, GPO contracts, and reimbursement data to enable clear visibility into net drug economics and informed purchasing decisions.

1 investor

Privia Health operates a network of physician practices organized for value-based care delivery, supporting independent practices and physicians across multiple specialties while maintaining clinical autonomy. The company works to improve patient outcomes and practice economics through its capital-efficient model.

1 investor